SHORT_NAME	LONG_NAME	ABSTRACT	CANCER_SITE	PATIENT_ID_NAME	INTEGRATED	OVERALL_ACCESS	SCHEMA_NAME	USE_IN_GUI	CONTENT_TYPES	SHOW_CONTENT_IN_GUI
ZHANG	The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy	Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature	BREAST	Sample iid	1	PUBLIC	ZHANG	1	CLINIC, MICROARRAY	1, 1
